T
VXRT

Transce3nd’s Vaxart VXRT Stock Holding History

Transce3nd’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-235
Closed -$156 – 1600
2024
Q4 		$156 Buy
+235
New +$163 ﹤0.01% 1491

Other funds holding VXRT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Transce3nd's VXRT Position: Q1 2025 in Review

Transce3nd sold out of Vaxart (VXRT) in Q1 2025, closing a stake of 235 shares — an estimated $156 sold.

Transce3nd first reported a position in VXRT in Q4 2024 and held it in 1 quarter. The position peaked at $156 in Q4 2024. 92 funds tracked by Wall St. Rank hold VXRT as of Q1 2025.

  • Transce3nd reported no remaining Vaxart position as of Q1 2025 after selling out during the quarter.
  • Transce3nd sold 235 Vaxart shares in Q1 2025, an estimated $156.
  • Transce3nd first reported a position in Vaxart in Q4 2024 and held it in 1 quarter.
  • Transce3nd's Vaxart position peaked at $156 in Q4 2024.
  • 92 funds tracked by Wall St. Rank held Vaxart as of Q1 2025.

Based on Transce3nd's 13F filing for Q1 2025, filed 5 May 2025.